Skip to content
healthcare.dev

doxorubicin hydrochloride

NDC 46708-810, doxorubicin hydrochloride, injection, suspension, liposomal, from Alembic Pharmaceuticals Limited.

Product NDC
46708-810
Status
Listed
Labeler
Alembic Pharmaceuticals Limited
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219199
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/46708-810 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
46708-810-10467080810101 VIAL, SINGLE-DOSE in 1 CARTON (46708-810-10) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f8e001f5-441c-47cd-86f6-5d5e3de16bc0

Use it

Look up 46708-810 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/46708-810 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 46708-810. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.